Grifols (GIFLF) Gross Margin Growth (5y) (2015 - 2025)
Powered by 
Analysis
Grifols (GIFLF) Gross Margin Growth (5y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7,003.00 |
| Dec 31, 2024 | -761.00 |
| Dec 31, 2021 | -5,086.00 |
| Dec 31, 2020 | -8,111.00 |
| Mar 31, 2020 | -394.00 |
| Dec 31, 2019 | 2,819.00 |
| Mar 31, 2019 | -707.00 |
| Dec 31, 2018 | -212,825.00 |
| Jun 30, 2018 | -456.00 |
| Mar 31, 2018 | -341.00 |
| Dec 31, 2017 | -191,882.00 |
| Jun 30, 2017 | -187.00 |
| Mar 31, 2017 | 136.00 |
| Dec 31, 2016 | -2,119.00 |
| Sep 30, 2016 | 40.00 |
| Jun 30, 2016 | 326.00 |
| Mar 31, 2016 | 3,734.00 |
| Dec 31, 2015 | 9,954.00 |
| Sep 30, 2015 | -2,955.00 |